Histological effects of endocrine therapy for prostatic cancer in relation to clinical course. 1989

S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
Department of Urology, School of Medicine, Chiba University.

In order to evaluate histological changes in cases of prostatic cancer following endocrine therapy, 25 extensive specimens were removed from prostates during periods of local control, and were examined with respect to prognosis. Shortly after the commencement of the endocrine therapy, there were noticeable degenerative changes in the cancer cells as well as structural changes such as desquamation of cells and loss of cancer nests. Later than two months from the start of therapy, stromal changes such as fibrosis and scar formation appeared. Coagulation necrosis of tumor tissue, inflammatory cell infiltration and granulomatous reactions were not as prominent. Within the first two months of treatment, the endocrine therapy uniformly affected the cancer tissues to some extent. After then, some showed relapsing viable cells in a part of the tumor, being judged to be no response. The others continued to respond to the therapy. The response was estimated as marked when such therapeutic changes appeared diffusely and profoundly over the tissues removed. Patients with a marked response had a good prognosis, indicating histological evaluation after endocrine therapy to provide a prognostic factor.

UI MeSH Term Description Entries
D008297 Male Males
D008679 Metaplasia A condition in which there is a change of one adult cell type to another similar adult cell type.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009919 Orchiectomy The surgical removal of one or both testicles. Castration, Male,Orchidectomy,Castrations, Male,Male Castration,Male Castrations,Orchidectomies,Orchiectomies
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D004054 Diethylstilbestrol A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) Stilbestrol,Agostilben,Apstil,Diethylstilbestrol, (Z)-Isomer,Diethylstilbestrol, Disodium Salt,Distilbène,Stilbene Estrogen,Tampovagan,Estrogen, Stilbene

Related Publications

S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
October 1990, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
July 1996, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
April 1982, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
March 1978, Neurochirurgia,
S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
November 1963, Polski przeglad chirurgiczny,
S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
September 1984, Clinical pharmacology and therapeutics,
S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
July 1985, Gan no rinsho. Japan journal of cancer clinics,
S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
January 1992, Advances in experimental medicine and biology,
S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
November 1983, Seminars in urology,
S Isaka, and S Teshima, and K Akakura, and T Igarashi, and S Murakami, and J Shimazaki
December 1958, British journal of urology,
Copied contents to your clipboard!